Carlson Capital’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-8,600
| Closed | -$775K | – | 53 |
|
|
2024
Q4 | $775K | Buy |
+8,600
| New | +$775K | 0.46% | 16 |
|
|
2024
Q1 | – | Sell |
-53,000
| Closed | -$4.73M | – | 156 |
|
|
2023
Q4 | $4.73M | Sell |
53,000
-33,400
| -39% | -$2.98M | 0.38% | 71 |
|
|
2023
Q3 | $6.31M | Buy |
86,400
+24,000
| +38% | +$1.75M | 0.49% | 60 |
|
|
2023
Q2 | $5.19M | Sell |
62,400
-4,900
| -7% | -$408K | 0.44% | 65 |
|
|
2023
Q1 | $5.13M | Buy |
+67,300
| New | +$5.13M | 0.48% | 56 |
|
|
2022
Q3 | – | Sell |
-39,900
| Closed | -$2.96M | – | 142 |
|
|
2022
Q2 | $2.96M | Sell |
39,900
-11,100
| -22% | -$824K | 0.2% | 90 |
|
|
2022
Q1 | $4.58M | Sell |
51,000
-3,000
| -6% | -$270K | 0.31% | 85 |
|
|
2021
Q4 | $6.05M | Buy |
54,000
+21,200
| +65% | +$2.37M | 0.35% | 68 |
|
|
2021
Q3 | $4.12M | Buy |
32,800
+900
| +3% | +$113K | 0.22% | 104 |
|
|
2021
Q2 | $4.32M | Buy |
+31,900
| New | +$4.32M | 0.21% | 95 |
|